Gyon Technologies Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-16,079
| Closed | -$1.66M | – | 71 |
|
|
2022
Q4 | $1.66M | Buy |
16,079
+9,653
| +150% | +$999K | 0.62% | 49 |
|
|
2022
Q3 | $545K | Sell |
6,426
-12,090
| -65% | -$1.03M | 0.17% | 138 |
|
|
2022
Q2 | $1.53M | Buy |
+18,516
| New | +$1.53M | 0.43% | 75 |
|
|
2022
Q1 | – | Sell |
-9,917
| Closed | -$876K | – | 302 |
|
|
2021
Q4 | $876K | Buy |
+9,917
| New | +$876K | 0.16% | 179 |
|
|
2021
Q1 | – | Sell |
-3,627
| Closed | -$318K | – | 409 |
|
|
2020
Q4 | $318K | Sell |
3,627
-2,594
| -42% | -$227K | 0.11% | 245 |
|
|
2020
Q3 | $473K | Buy |
+6,221
| New | +$473K | 0.37% | 103 |
|
|
2020
Q1 | – | Sell |
-20,049
| Closed | -$1.7M | – | 112 |
|
|
2019
Q4 | $1.7M | Buy |
+20,049
| New | +$1.7M | 1.12% | 41 |
|